The US Department of Justice has announced a major shift in federal marijuana policy that could ease regulations for state-licensed medical cannabis businesses across the country.
Under a new order signed by acting Attorney General Todd Blanche, many state-approved medical marijuana products will move from Schedule I to Schedule III under federal drug classifications.
The change could significantly affect marijuana businesses in states such as Missouri, where both medical and recreational cannabis sales are legal under state law. [Read more…] about DOJ eases federal restrictions on medical marijuana in major policy shift